Perspective Therapeutics CATX Free cash flow
Free cash flow at other companies
Other financials
Where this comes from
Calculated from Perspective Therapeutics’s reported figures.
The official record: Perspective Therapeutics’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about Perspective Therapeutics's free cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Perspective Therapeutics's free cash flow?
- Perspective Therapeutics (CATX) reported free cash flow of -$38.33M in Q1 2026.
- How has Perspective Therapeutics's free cash flow changed year-over-year?
- Perspective Therapeutics's free cash flow decreased by 46.1% year-over-year, from -$26.24M to -$38.33M.
- What is the long-term trend for Perspective Therapeutics's free cash flow?
- Over 2 years (2023 to 2025), Perspective Therapeutics's free cash flow has grown at a 58.3% compound annual growth rate (CAGR), from -$37.99M to -$95.23M.
- What does free cash flow mean?
- Free cash flow represents the cash generated by a company after accounting for cash outflows to support operations and maintain or expand its capital asset base. It serves as a critical indicator of a company's ability to fund organic growth, pay down debt, or return capital to shareholders without relying on external financing.